Hannover Re/€HNR1

05:30
15:10
00:45
10:25
20:00
1D1W1MYTD1Y5YMAX

About Hannover Re

Hannover Re, known formally as Hannover Rück SE, is a global reinsurance company headquartered in Hannover, Germany. Founded in 1966, the company operates in the insurance sector, providing reinsurance products and services across both life/health and property/casualty lines. Hannover Re ranks as the third-largest reinsurance group in the world and is listed on the Frankfurt Stock Exchange under the ticker symbol HNR1.

Ticker

€HNR1
Sector

Primary listing

XETRA

Employees

4,013

Hannover Re Metrics

BasicAdvanced
€31B
12.68
€20.58
0.38
€9.00
2.68%

What the Analysts think about Hannover Re

Analyst ratings (Buy, Hold, Sell) for Hannover Re stock.

Bulls say / Bears say

Hannover Re raised its dividend payout target from 46% to 55% of IFRS Group net income and merged its special dividend into the regular payout, underscoring its robust capital position. (Reuters)
The company’s second-quarter net profit rose to €833 million from €603 million a year earlier, driven by lower catastrophe costs, with gross reinsurance revenue up to €6.37 billion and a service result of €905 million, while maintaining its full-year guidance. (WSJ)
Hannover Re achieved a 7.6% increase in premium volume at the January 1 property and casualty renewals and confirmed its guidance for around €2.4 billion in net income for 2025, highlighting ongoing client demand and profitable growth. (Reuters via TradingView)
Hannover Re’s first-quarter profit fell 14% to €480 million after incurring €631 million in claims from the California wildfires, pushing its combined ratio above 93%, well above its target of under 88%. (Reuters)
The company faced pricing pressure with an average 2.1% inflation- and risk-adjusted price decline across its Jan. 1 renewals, as increased market capacity led to rate erosion in non-catastrophe lines. (Reuters via TradingView)
Hannover Re announced it will exit the Viridium consortium on September 30, 2025, signaling reduced focus on acquiring closed life insurance portfolios and potentially limiting its life and health segment diversification. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 10 Oct 2025.

Hannover Re Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Hannover Re Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €HNR1

Sign up or log in to buy
Capital at risk
Extended hours trading

Upcoming events

No upcoming events
FAQs